A novel Rb- and p300-binding protein inhibits transactivation by MyoD

Molecular and Cellular Biology

Volumn 20, Issue 23, 2000, Pages 8903-8915

  MacLellan, W R ^a   Xiao, G ^a   Abdellatif, M ^a   Schneider, M D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL PROTEIN; HISTONE ACETYLTRANSFERASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MYOD PROTEIN; PROTEIN EID 1; PROTEIN P300; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; SKELETAL MUSCLE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ACETYLTRANSFERASES; ADENOVIRUS E1A PROTEINS; AMINO ACID SEQUENCE; CLONING, MOLECULAR; GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYOD PROTEIN; NUCLEAR PROTEINS; PROTEIN BINDING; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; SACCHAROMYCES CEREVISIAE PROTEINS; TISSUE DISTRIBUTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TWO-HYBRID SYSTEM TECHNIQUES;

ANIMALIA; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS PHAGE 187;

EID: 0034460363     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.23.8903-8915.2000     Document Type: Article

References (77)

1. An effector-like function of Ras GTPase-activating protein predominates in cardiac muscle ceils
2. Cardiac actin is the major actin gene product in skeletal muscle cell differentiation in vitro
3. Adenovirus E1A inhibits cardiac myocyte-specific gene expression through its amino terminus
4. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein
5. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity
6. A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor
7. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6
8. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs
9. Binding of an interferon-inducible protein (p202) to the retinoblastoma protein
10. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site
11. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit
12. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins
13. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor
14. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation
15. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes
16. Improved method for high efficiency transformation of intact yeast cells
17. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
18. Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast
19. Inhibition of myogenesis by multiple cyclinCdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F
20. Identification of multiple proteins that interact with functional regions of the human cardiac alpha-actin promoter
21. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A
22. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclindependent kinases
23. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene
24. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli
25. The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells
26. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein
27. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4
28. The retinoblastoma gene product regulates Sp1-mediated transcription
29. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription
30. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains
31. Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates
32. Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization
33. The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A
34. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation
35. Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myogenesis
36. The retinoblastoma gene family in differentiation and development
37. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein
38. Transforming growth factor-β response elements of the skeletal α-actin gene
39. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation
40. Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle
41. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins
42. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle
43. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation
44. The transcriptional coactivators p300 and CBP are histone acetyltransferases
45. Serum response factor mediates AP-1-dependent induction of the skeletal α-actin promoter in ventricular myocytes
46. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes
47. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription
48. The transcription factor E2F-1 is a downstream target of RB action
49. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators
50. MyoD meets its maker
51. GAL4-VP16 is an unusually potent transcriptional activator
52. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C
53. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program
54. -/- muscle cells
55. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth
56. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites
57. Regulation of differentiation by HBP1, a target of the retinoblastoma protein
58. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner
59. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor
60. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation
61. Analysis of E1A-mediated growth regulation functions: Binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity
62. Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene
63. Rede-fining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD
64. Cardiac myocyte terminal differentiation. Potential for cardiac regeneration
65. RB kinases and RB-binding proteins: New points of view
66. Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms
67. E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP
68. Myogenin is required for late but not early aspects of myogenesis during mouse development
69. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1
70. Mechanism of active transcriptional repression by the retinoblastoma protein
71. The retinoblastoma gene: Role in cell cycle control and cell differentiation
72. Protein-peptide interactions analyzed with the yeast two-hybrid system
73. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
74. Human p300 protein is a coactivator for the transcription factor MyoD